MoneyWorks4Me

Windlas Biotech - Quaterly Results

22 May 2026 Evaluate
The March 2026 quarter revenue stood at Rs. 2384.99 millions, up 17.66% as compared to Rs. 2027.05 millions during the corresponding quarter last year.The Company's Net profit for the March 2026 quarter have declined marginally to Rs. 160.16  millions as against Rs. 162.85 millions reported during the corresponding quarter ended.Operating profit for the quarter ended March 2026 decreased to 296.36 millions as compared to 304.89 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 2384.99 2027.05 17.66 9040.89 7598.78 18.98 9040.89 7598.78 18.98
Other Income 43.98 49.41 -10.99 178.04 176.46 0.90 178.04 176.46 0.90
PBIDT 296.36 304.89 -2.80 1224.99 1117.61 9.61 1224.99 1117.61 9.61
Interest 14.75 13.27 11.15 48.25 43.82 10.11 48.25 43.82 10.11
PBDT 281.61 291.62 -3.43 1176.74 1073.79 9.59 1176.74 1073.79 9.59
Depreciation 79.99 83.35 -4.03 307.43 279.85 9.86 307.43 279.85 9.86
PBT 201.62 208.27 -3.19 869.31 793.94 9.49 869.31 793.94 9.49
TAX 41.46 45.42 -8.72 204.96 187.45 9.34 204.96 187.45 9.34
Deferred Tax -6.64 -0.64 937.50 -2.03 4.72 -143.01 -2.03 4.72 -143.01
PAT 160.16 162.85 -1.65 664.35 606.49 9.54 664.35 606.49 9.54
Equity 105.53 104.80 0.70 105.53 104.80 0.70 105.53 104.80 0.70
PBIDTM(%) 12.43 15.04 -17.39 13.55 14.71 -7.88 13.55 14.71 -7.88
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..